Sabra Healthcare REIT (NASDAQ:SBRA) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of Sabra Healthcare REIT (NASDAQ:SBRA) from a sell rating to a hold rating in a report released on Saturday morning.

A number of other equities analysts have also recently weighed in on SBRA. Weiss Ratings reaffirmed a “buy (b)” rating on shares of Sabra Healthcare REIT in a report on Wednesday, October 8th. Wells Fargo & Company boosted their price objective on Sabra Healthcare REIT from $20.00 to $21.00 and gave the company an “overweight” rating in a research report on Tuesday, November 25th. National Bankshares set a $22.00 target price on Sabra Healthcare REIT in a research note on Friday, October 17th. UBS Group began coverage on Sabra Healthcare REIT in a research report on Tuesday, November 18th. They set a “neutral” rating and a $20.00 target price on the stock. Finally, Jefferies Financial Group reissued a “buy” rating and issued a $22.00 price target on shares of Sabra Healthcare REIT in a research note on Monday, December 15th. One research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and five have issued a Hold rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $21.00.

Sabra Healthcare REIT Stock Performance

SBRA opened at $19.08 on Friday. The firm has a fifty day moving average price of $18.78 and a 200 day moving average price of $18.62. Sabra Healthcare REIT has a 1 year low of $15.60 and a 1 year high of $19.97. The stock has a market cap of $4.76 billion, a P/E ratio of 26.50, a P/E/G ratio of 1.17 and a beta of 0.67. The company has a debt-to-equity ratio of 0.92, a current ratio of 5.19 and a quick ratio of 5.19.

Sabra Healthcare REIT (NASDAQ:SBRA) last released its quarterly earnings data on Wednesday, November 5th. The real estate investment trust reported $0.38 earnings per share for the quarter, beating analysts’ consensus estimates of $0.37 by $0.01. The company had revenue of $190.04 million during the quarter, compared to analysts’ expectations of $193.44 million. Sabra Healthcare REIT had a net margin of 23.50% and a return on equity of 6.38%. The firm’s revenue for the quarter was up 6.7% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.37 earnings per share. Sabra Healthcare REIT has set its FY 2025 guidance at 1.455-1.465 EPS. Equities research analysts anticipate that Sabra Healthcare REIT will post 1.45 earnings per share for the current year.

Sabra Healthcare REIT Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, November 28th. Stockholders of record on Monday, November 17th were given a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 6.3%. The ex-dividend date was Monday, November 17th. Sabra Healthcare REIT’s dividend payout ratio (DPR) is 166.67%.

Institutional Trading of Sabra Healthcare REIT

Several large investors have recently made changes to their positions in the company. Founders Capital Management purchased a new position in Sabra Healthcare REIT in the 3rd quarter valued at $28,000. Danske Bank A S acquired a new stake in shares of Sabra Healthcare REIT in the third quarter valued at about $30,000. Larson Financial Group LLC lifted its stake in shares of Sabra Healthcare REIT by 42.3% in the third quarter. Larson Financial Group LLC now owns 1,860 shares of the real estate investment trust’s stock worth $35,000 after buying an additional 553 shares in the last quarter. Covestor Ltd boosted its position in Sabra Healthcare REIT by 23,720.0% during the third quarter. Covestor Ltd now owns 2,382 shares of the real estate investment trust’s stock worth $45,000 after acquiring an additional 2,372 shares during the last quarter. Finally, EverSource Wealth Advisors LLC boosted its position in Sabra Healthcare REIT by 150.7% during the second quarter. EverSource Wealth Advisors LLC now owns 2,555 shares of the real estate investment trust’s stock worth $47,000 after acquiring an additional 1,536 shares during the last quarter. 99.40% of the stock is currently owned by hedge funds and other institutional investors.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.